Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology. | PLoS One | 2021 | 34879110 | PubTator, text mining | PubMed |
| CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients. | J Oncol | 2021 | 34876903 | PubTator, text mining | PubMed |
| Colloidal Self-Assembled Patterns Maintain the Pluripotency and Promote the Hemopoietic Potential of Human Embryonic Stem Cells. | Front Cell Dev Biol | 2021 | 34869369 | PubTator, text mining | PubMed |
| Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. | J Immunol Res | 2021 | 34859106 | PubTator, text mining | PubMed |
| Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC. | J Hepatocell Carcinoma | 2021 | 34849372 | PubTator, text mining | PubMed |
| The Lymphatic System in Breast Cancer: Anatomical and Molecular Approaches. | Medicina (Kaunas) | 2021 | 34833492 | PubTator, text mining | PubMed |
| Immune Response of Senegalese Sole against Betanodavirus Mutants with Modified Virulence. | Pathogens | 2021 | 34832544 | PubTator, text mining | PubMed |
| Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. | Cancers (Basel) | 2021 | 34830902 | PubTator, text mining | PubMed |
| High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. | Nat Commun | 2021 | 34824220 | PubTator, text mining | PubMed |
| Papillary Thyroid Carcinoma Landscape and Its Immunological Link With Hashimoto Thyroiditis at Single-Cell Resolution. | Front Cell Dev Biol | 2021 | 34805166 | PubTator, text mining | PubMed |
| Transcriptome Profile During Rabies Virus Infection: Identification of Human CXCL16 as a Potential New Viral Target. | Front Cell Infect Microbiol | 2021 | 34804996 | PubTator, text mining | PubMed |
| Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10. | World J Surg Oncol | 2021 | 34794429 | PubTator, text mining | PubMed |
| A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes. | Ann Transl Med | 2021 | 34790776 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression. | Front Endocrinol (Lausanne) | 2021 | 34790166 | PubTator, text mining | PubMed |
| CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway. | J Ovarian Res | 2021 | 34789307 | PubTator, text mining | PubMed |
| Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. | J Immunother Cancer | 2021 | 34782430 | PubTator, text mining | PubMed |
| The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood. | Front Immunol | 2021 | 34777354 | PubTator, text mining | PubMed |
| PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer. | Front Immunol | 2021 | 34777336 | PubTator, text mining | PubMed |
| Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis. | Arthritis Res Ther | 2021 | 34774095 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation. | Int J Mol Sci | 2021 | 34769520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=50